The ACC is seeking comments on a draft of the 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients with Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or with Atherosclerotic Cardiovascular Disease.

The document aims to provide clear, point-of-care guidance on the best approach for dual antiplatelet therapy and oral anticoagulant management at the intersection of PCI, venous thromboembolism and atrial fibrillation.

Comments are due by Wednesday, March 11.

Access the document and public comment response form here and submit comments to pathwaycomment@acc.org.